Iodomethane

Iodomethane

SCHEMBL4635672

CI.Cc1ccc(S(=O)(=O)OCCOc2ccc3c(c2)c(S(=O)(=O)c2cccc4ccccc24)nn3C)cc1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 18/20 0.51
HTR2B P41595 6/20 0.50
DRD2 P14416 4/20 0.50
HTR2C P28335 4/20 0.50
HTR1A P08908 1/20 0.50
HTR1D P28221 1/20 0.50
HTR1B P28222 1/20 0.50
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3532315 0.98 HTR6 (0.53) HTR6HTR2BDRD2HTR2CHTR1A
SCHEMBL3531703 0.86 HTR6 (0.57) HTR6HTR2BDRD2HTR2CHTR1A
SCHEMBL3532161 0.83 HTR6 (0.51) HTR6HTR2BDRD2HTR2CHTR1A
SCHEMBL3531918 0.81 HTR6 (0.59) HTR6HTR2BDRD2HTR2CHTR1A
SCHEMBL3528252 0.80 HTR6 (0.56) HTR6HTR2BDRD2HTR2CHTR1A
SCHEMBL3533507 0.80 HTR6 (0.56) HTR6HTR2BDRD2HTR2CHTR1A
SCHEMBL3531152 0.80 HTR6 (0.47) HTR6HTR2BDRD2HTR2CCA12
SCHEMBL4635313 0.80 HTR6 (0.48) HTR6HTR2BDRD2HTR2CHTR1A
SCHEMBL3531095 0.79 HTR6 (0.54) HTR6HTR2BDRD2HTR2CHTR1A
SCHEMBL3531740 0.79 HTR6 (0.54) HTR6HTR2BDRD2HTR2CHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1931640-A2 SUBSTITUTED-3-SULFONYLINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS Wyeth a Corporation of the State of Delaware (US) 2008-06-18 EP disclosed
WO-2007021711-A2 SUBSTITUTED-3-SULFONYLINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2007-02-22 WO disclosed